Connection
Josephine Harrington to Glucagon-Like Peptide 1
This is a "connection" page, showing publications Josephine Harrington has written about Glucagon-Like Peptide 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.212 |
|
|
|
-
Lehenbauer KS, Nelson AJ, Nodari S, Sverdlov AL, Harrington J. The impact of oral semaglutide on cardiovascular events in patients with type 2 diabetes: review of results from the SOUL trial. Heart Fail Rev. 2025 12 10; 31(1):11.
Score: 0.212